|
|
||||||||
Division of Arthritis Research, Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037
This study addresses the effects of IL-1ß on apoptosis induced by
agonistic anti-CD95 (Fas) Ab. IL-1ß inhibited anti-CD95
Ab-induced apoptosis in all preparations of normal human articular
chondrocytes tested. Inhibitors of nitric oxide synthase or
cyclooxygenase did not influence the protective effect of IL-1ß,
indicating that nitric oxide and PGs were not involved in the
modulation of CD95-induced apoptosis. However, when the
IL-1ß-dependent induction of NF-
B was inhibited, the antiapoptotic
effect of IL-1ß was partially reversed, suggesting that
NF-
B-mediated gene activation is part of the protective mechanism.
In addition, IL-1ß significantly increased the expression of Bcl-2.
The protein tyrosine kinase inhibitor herbimycin A completely
eliminated the protective effect of IL-1ß on CD95-induced apoptosis.
These findings suggest that IL-1ß modulates the CD95 death cascade in
chondrocytes by mechanisms that involve tyrosine phosphorylation events
and NF-
B-dependent gene activation.
This article has been cited by other articles:
![]() |
C.-Y. Yang, T.-H. Kuo, and L.-P. Ting Human Hepatitis B Viral e Antigen Interacts with Cellular Interleukin-1 Receptor Accessory Protein and Triggers Interleukin-1 Response J. Biol. Chem., November 10, 2006; 281(45): 34525 - 34536. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M Smith, S. Lecour, and M. N Sack Innate immunity and cardiac preconditioning: a putative intrinsic cardioprotective program Cardiovasc Res, August 15, 2002; 55(3): 474 - 482. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |